Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Stichting Hemato-Oncologie voor Volwassenen Nederland
University of Leeds
Mayo Clinic
University of Turin, Italy
Nantes University Hospital
University of California, San Francisco
Northwestern University
University of Leipzig
Fondazione EMN Italy Onlus
Fred Hutchinson Cancer Center